Impact of Preoperative Narcotic Use on Outcomes in Migraine Surgery
Authors:
- Matthew BrownMBMatthew Brown
- Deborah ReedDRDeborah Reed
- Bahman GuyuronBGBahman Guyuron
- 1 July 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 134 (1) , 113-119
Abstract
This study focuses on the impact of preoperative narcotic medication use on outcomes of surgical treatment of migraine headaches. A retrospective comparative review was conducted with patients undergoing migraine surgery. Data gathered included demographic information, baseline migraine headache characteristics, migraine surgery sites, postoperative migraine headache characteristics 1 year or more following surgery, and preoperative migraine medication use. Patients were grouped based on preoperative narcotic medication use. The narcotic users were subdivided into low and high narcotic user groups. Preoperative migraine characteristics were comparable between groups and the outcomes of migraine surgery were compared between the groups. Outcomes in 90 narcotic users were compared with those for 112 patients not using narcotic medications preoperatively. Narcotic users showed statistically significantly less reduction in frequency, severity, and duration of migraine headaches after surgery. Narcotic users had clinical improvement in 66.7 percent of patients and elimination in 18.9 percent versus 86.6 and 36.6 percent, respectively, in the nonnarcotic group. The group that consumed narcotics had significantly lower rates of improvement in all migraine indices. Previous studies have discouraged the routine use of narcotic medications in the management of migraine medications. The authors' study demonstrates that narcotic medication use before migraine headache surgery may predispose patients to worse outcomes postoperatively. Because pain cannot be objectively documented, the question remains of whether this failure to improve the pain was indeed a suboptimal response to surgery or the need for narcotic substances. Risk, II.Keywords
This publication has 17 references indexed in Scilit:
- Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and μ opioid receptor expression in neuropathic miceBrain, Behavior, and Immunity, 2013
- Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatmentCephalalgia, 2012
- Opioid Use and Dependence Among Persons With Migraine: Results of the AMPP StudyHeadache: The Journal of Head and Face Pain, 2012
- Opiate and Opioid (“Narcotic”) Therapy for Acute Migraine HeadacheHeadache: The Journal of Head and Face Pain, 2010
- Migraine pathogenesis and state of pharmacological treatment optionsBMC Medicine, 2009
- A Placebo-Controlled Surgical Trial of the Treatment of Migraine HeadachesPlastic and Reconstructive Surgery, 2009
- Morphine Enhances Microglial Migration through Modulation of P2X4Receptor SignalingJournal of Neuroscience, 2009
- Rebound Abdominal Pain: Noncephalic Pain in Abdominal Migraine is Exacerbated by Medication OveruseHeadache: The Journal of Head and Face Pain, 2008
- Burden of Migraine in the United StatesArchives of internal medicine (1960), 1999
- AlgorithmNeurology, 1994